QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文 THORACIC CANCER, 2022 作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo 收藏  |  浏览/下载：40/0  |  提交时间：2022/12/23 checkpoint inhibitor pneumonitis  Chinese experts consensus  immune checkpoint inhibitor-related adverse effects   Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文 THORACIC CANCER, 2022 作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo 收藏  |  浏览/下载：51/0  |  提交时间：2022/12/22 fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase   Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文 BMC PULMONARY MEDICINE, 2022, 卷号: 22 作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan 收藏  |  浏览/下载：25/0  |  提交时间：2022/12/23 Non-small cell lung cancer  Prognosis  Angiogenesis  Tyrosine kinase inhibitors   Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report 期刊论文 TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11 作者:  Gu, Xiaodong;  Wang, Wenxian;  Wu, Wei;  Zhang, Yiping;  Shao, Lan 收藏  |  浏览/下载：18/0  |  提交时间：2022/12/22 Non-small cell lung cancer (NSCLC)  HIVEP1-ALK  alectinib  intergenic region (IGR)  case report   Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文 GENES CHROMOSOMES & CANCER, 2022 作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping 收藏  |  浏览/下载：34/0  |  提交时间：2022/05/16 BRAF mutation  immune checkpoint inhibitors  non-small cell lung cancer  PD-L1  targeted therapy